News
03-23-2015, 03:02 AM
A pioneering class of drugs that target cancers with mutations in the BRCA breast cancer genes could also work against tumours with another type of genetic fault, a new study suggests.
More... (http://www.medicalnewstoday.com/releases/291222.php)
More... (http://www.medicalnewstoday.com/releases/291222.php)